{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T18:59:25Z","timestamp":1793386765287,"version":"4.5.0"},"reference-count":78,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pharmacol."],"abstract":"<jats:p>Fluoroquinolones are a cornerstone of human antibacterial chemotherapy because they combine broad-spectrum bactericidal activity, high oral bioavailability, and excellent tissue penetration. However, their clinical utility is being eroded by the global spread of multidrug-resistant (MDR) pathogens. While quinolone resistance-determining region (QRDR) mutations in DNA gyrase and topoisomerase IV remain the primary determinants of high-level resistance, mounting evidence implicates active efflux pump overexpression as an important exposure-modifying mechanism. This mechanism can amplify multidrug resistance. This review provides a pharmacology-centered synthesis of fluoroquinolone mechanism of action, pharmacokinetic\/pharmacodynamic (PK\/PD) indices, and the mutant selection window (MSW) framework, and integrates these concepts with the structural and regulatory biology of efflux systems in major human ESKAPE pathogens. We highlight how resistance-nodulation-division (RND) pumps in Gram-negative bacteria (e.g., AcrAB-TolC, Mex-family systems) and major facilitator superfamily (MFS) pumps in Gram-positive cocci (e.g., NorA\/NorB\/NorC) lower intracellular drug exposure, widen the MSW, and promote stepwise acquisition of QRDR mutations and plasmid-mediated quinolone resistance. Using recent WHO GLASS data and health-economic analyses, we summarize global resistance trends and discuss the broader healthcare and macroeconomic burden associated with MDR bacterial infections. Finally, we discuss translational strategies to mitigate efflux-mediated resistance, including the preclinical pipeline of efflux pump inhibitors (EPIs), PK\/PD-informed high-exposure dosing regimens, and One Health-aligned antimicrobial stewardship interventions. By linking molecular mechanism, PK\/PD, epidemiology, and health economics, this review aims to inform rational dosing, drug development, and policy decisions needed to preserve the efficacy of this vital antimicrobial class.<\/jats:p>","DOI":"10.3389\/fphar.2026.1897593","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:48:53Z","timestamp":1784728133000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Efflux pump overexpression in fluoroquinolone multidrug resistance: molecular mechanisms, PK\/PD implications, global epidemiology, and translational strategies"],"prefix":"10.3389","volume":"17","author":[{"given":"Ahmad H.","family":"Alhowail","sequence":"first","affiliation":[{"name":"Department of Pharmacology and Toxicology, College of Pharmacy, Qassim University","place":["Buraydah, Al Qassim, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasser S.","family":"Almogbel","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Practice, College of Pharmacy, Qassim University","place":["Buraydah, Al Qassim, Saudi Arabia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"e0297921","DOI":"10.1371\/journal.pone.0297921","article-title":"Global antimicrobial resistance and use surveillance system (GLASS 2022): investigating the relationship between antimicrobial resistance and antimicrobial consumption data across the participating countries","volume":"19","author":"Ajulo","year":"2024","journal-title":"PLOS One"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1021\/bi5000564","article-title":"Mechanism of quinolone action and resistance","volume":"53","author":"Aldred","year":"2014","journal-title":"Biochemistry"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/j.cell.2007.03.004","article-title":"Molecular mechanisms of antibacterial multidrug resistance","volume":"128","author":"Alekshun","year":"2007","journal-title":"Cell"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e0261970","DOI":"10.1371\/journal.pone.0261970","article-title":"High prevalence of plasmid-mediated quinolone resistance (PMQR) among E. coli from aquatic environments in Bangladesh","volume":"16","author":"Amin","year":"2021","journal-title":"PLoS ONE"},{"key":"B5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fmicb.2019.00044","article-title":"Multidrug-resistant Enterobacter cloacae complex emerging as a global, diversifying threat","volume":"10","author":"Annavajhala","year":"2019","journal-title":"Front. Microbiol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","year":"2022","journal-title":"Lancet"},{"key":"B7","doi-asserted-by":"publisher","first-page":"11786302251342936","DOI":"10.1177\/11786302251342936","article-title":"Molecular characterization of plasmid-mediated quinolone resistance genes in multidrug-resistant Escherichia coli isolated from wastewater generated from the hospital environment","volume":"19","author":"Banjo","year":"2025","journal-title":"Environ. Health Insights"},{"key":"B8","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/j.1574-6968.2001.tb10631.x","article-title":"Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary and human clinical isolates of Pseudomonas aeruginosa","volume":"198","author":"Beinlich","year":"2001","journal-title":"FEMS Microbiol. Lett."},{"key":"B9","doi-asserted-by":"publisher","first-page":"2513","DOI":"10.1128\/AAC.43.10.2513","article-title":"Association of alterations in ParC and GyrA proteins with resistance of clinical isolates of Enterococcus faecium to nine different fluoroquinolones","volume":"43","author":"Brisse","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B10","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/zph.13110","article-title":"High occurrence of ST131 among extraintestinal pathogenic Escherichia coli from companion and human clinical isolates","volume":"72","author":"Carvalho","year":"2024","journal-title":"Zoonoses Public Health"},{"key":"B11","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1021\/acsinfecdis.4c00128","article-title":"Gyrase and topoisomerase IV: recycling old targets for new antibacterials to combat fluoroquinolone resistance","volume":"10","author":"Collins","year":"2024","journal-title":"ACS Infect. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1128\/AAC.00155-10","article-title":"Overexpression of resistance-nodulation-cell division pump AdeFGH confers multidrug resistance in Acinetobacter baumannii","volume":"54","author":"Coyne","year":"2010","journal-title":"Antimicrob. Agents Chemother."},{"key":"B13","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.01388-10","article-title":"Efflux-mediated antibiotic resistance in Acinetobacter spp","volume":"55","author":"Coyne","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"B14","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1128\/AAC.00732-07","article-title":"AdeIJK, a resistance-nodulation-cell division pump effluxing multiple antibiotics in Acinetobacter baumannii","volume":"52","author":"Damier-Piolle","year":"2008","journal-title":"Antimicrob. Agents Chemother."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e00002","DOI":"10.1128\/CMR.00002-19","article-title":"Enterobacter spp.: update on taxonomy, clinical aspects, and emerging antimicrobial resistance","volume":"32","author":"Davin-Regli","year":"2019","journal-title":"Clin. Microbiol. Rev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/jac\/dkg269","article-title":"The mutant selection window and antimicrobial resistance","volume":"52","author":"Drlica","year":"2003","journal-title":"J. Antimicrob. Chemother."},{"key":"B18","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1128\/mmbr.61.3.377-392.1997","article-title":"DNA gyrase, topoisomerase IV, and the 4-quinolones","volume":"61","author":"Drlica","year":"1997","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"B19","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1086\/511642","article-title":"Mutant selection window hypothesis updated","volume":"44","author":"Drlica","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"B20","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/s41579-018-0048-6","article-title":"Multidrug efflux pumps: structure, function and regulation","volume":"16","author":"Du","year":"2018","journal-title":"Nat. Rev. Microbiol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1128\/AAC.43.4.947","article-title":"Alterations in GyrA and ParC associated with fluoroquinolone resistance in Enterococcus faecium","volume":"43","author":"el Amin","year":"1999","journal-title":"Antimicrob. Agents Chemother."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1719066","DOI":"10.3389\/fmicb.2025.1719066","article-title":"Fluoroquinolone resistance in ESKAPE pathogens: evolutionary pathways, one health transmission, and clinical surveillance","volume":"16","author":"Elbehiry","year":"2025","journal-title":"Front. Microbiol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"7753","DOI":"10.1128\/AAC.01729-15","article-title":"Complex regulation pathways of AmpC-mediated \u03b2-lactam resistance in Enterobacter cloacae complex","volume":"59","author":"Gu\u00e9rin","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"B24","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1128\/AAC.02840-15","article-title":"Landscape of resistance-nodulation-cell division (RND)-type efflux pumps in Enterobacter cloacae complex","volume":"60","author":"Gu\u00e9rin","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"B25","doi-asserted-by":"publisher","first-page":"239","DOI":"10.4103\/cmi.cmi_86_25","article-title":"The rising price of resistance - confronting the cost of care in Gram-negative bacterial infections","volume":"23","author":"Gunasekaran","year":"2025","journal-title":"Curr. Med. Issues"},{"key":"B26","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1093\/jac\/dkm167","article-title":"Substrate specificity of the OqxAB multidrug resistance pump in Escherichia coli and selected enteric bacteria","volume":"60","author":"Hansen","year":"2007","journal-title":"J. Antimicrob. Chemother."},{"key":"B27","doi-asserted-by":"publisher","first-page":"104202","DOI":"10.1016\/j.micpath.2020.104202","article-title":"Frequency of efflux pump genes mediating ciprofloxacin and antiseptic resistance in methicillin-resistant Staphylococcus aureus isolates","volume":"144","author":"Hassanzadeh","year":"2020","journal-title":"Microb. Pathog."},{"key":"B28","doi-asserted-by":"publisher","first-page":"a025320","DOI":"10.1101\/cshperspect.a025320","article-title":"Topoisomerase inhibitors: fluoroquinolone mechanisms of action and resistance","volume":"6","author":"Hooper","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"B29","volume-title":"Drug-resistant infections: a threat to our economic future","author":"Jonas","year":"2017"},{"key":"B30","doi-asserted-by":"publisher","first-page":"5213","DOI":"10.1128\/jb.183.18.5213-5222.2001","article-title":"Overexpression of the MexEF-OprN multidrug efflux system affects cell-to-cell signaling in Pseudomonas aeruginosa","volume":"183","author":"Kohler","year":"2001","journal-title":"J. Bacteriol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e01373-22","DOI":"10.1128\/aac.01373-22","article-title":"Mutant prevention concentration, frequency of spontaneous mutant selection, and mutant selection window - a new approach to the in vitro determination of the antimicrobial potency of compounds","volume":"67","author":"Krajewska","year":"2023","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1016\/j.bbapap.2008.11.012","article-title":"Multidrug efflux transporters in the MATE family","volume":"1794","author":"Kuroda","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B33","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/pathogens10030373","article-title":"Acinetobacter baumannii antibiotic resistance mechanisms","volume":"10","author":"Kyriakidis","year":"2021","journal-title":"Pathogens"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.3390\/ani13071270","article-title":"Exploring efflux as a mechanism of reduced susceptibility towards biocides and fluoroquinolones in Staphylococcus pseudintermedius","volume":"13","author":"Leal","year":"2023","journal-title":"Animals"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1128\/JCM.44.3.1059-1064.2006","article-title":"High-level ciprofloxacin resistance from point mutations in gyrA and parC confined to global hospital-adapted clonal lineage CC17 of Enterococcus faecium","volume":"44","author":"Leavis","year":"2006","journal-title":"J. Clin. Microbiol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1128\/CMR.00117-14","article-title":"The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria","volume":"28","author":"Li","year":"2015","journal-title":"Clin. Microbiol. Rev."},{"key":"B37","doi-asserted-by":"publisher","first-page":"851813","DOI":"10.3389\/fmicb.2022.851813","article-title":"Plasmid-mediated quinolone resistance: mechanisms, detection and epidemiology in the one Health context","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Microbiol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1128\/AAC.48.5.1797-1802.2004","article-title":"Clinical strains of Pseudomonas aeruginosa overproducing MexAB-OprM and MexXY efflux pumps simultaneously","volume":"48","author":"Llanes","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B39","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.bcp.2005.12.008","article-title":"Practical applications and feasibility of efflux pump inhibitors in the clinic: a vision for applied use","volume":"71","author":"Lomovskaya","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1128\/AAC.45.1.105-116.2001","article-title":"Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy","volume":"45","author":"Lomovskaya","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B41","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","article-title":"Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa","volume":"23","author":"Lorusso","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"B42","doi-asserted-by":"publisher","first-page":"3375","DOI":"10.1128\/AAC.45.12.3375-3380.2001","article-title":"Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454","volume":"45","author":"Magnet","year":"2001","journal-title":"Antimicrob. Agents Chemother."},{"key":"B43","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1128\/AAC.48.9.3298-3304.2004","article-title":"Expression of the RND-type efflux pump AdeABC in Acinetobacter baumannii is regulated by the AdeRS two-component system","volume":"48","author":"Marchand","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"B44","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.tvjl.2005.07.010","article-title":"Pharmacology of the fluoroquinolones: a perspective for the use in domestic animals","volume":"172","author":"Martinez","year":"2006","journal-title":"Vet. J."},{"key":"B45","doi-asserted-by":"publisher","first-page":"649","DOI":"10.3855\/jidc.17304","article-title":"Antibiotic resistance assessment and multi-drug efflux pumps of Enterococcus faecium isolated from clinical specimens","volume":"17","author":"Mirzaii","year":"2023","journal-title":"J. Infect. Dev. Ctries."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00248-013-0297-x","article-title":"Pseudomonas aeruginosa biofilms in disease","volume":"68","author":"Mulcahy","year":"2014","journal-title":"Microb. Ecol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature05076","article-title":"Crystal structures of a multidrug transporter reveal a functionally rotating mechanism","volume":"443","author":"Murakami","year":"2006","journal-title":"Nature"},{"key":"B48","doi-asserted-by":"publisher","first-page":"e016249","DOI":"10.1136\/bmjgh-2024-016249","article-title":"The global economic burden of antibiotic-resistant infections and the potential impact of bacterial vaccines: a modelling study","volume":"10","author":"Naylor","year":"2025","journal-title":"BMJ Glob. Health"},{"key":"B49","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1128\/CMR.00125-13","article-title":"Escherichia coli ST131, an intriguing clonal group","volume":"27","author":"Nicolas-Chanoine","year":"2014","journal-title":"Clin. Microbiol. Rev."},{"key":"B50","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1128\/AAC.01866-13","article-title":"Characterization of a novel pyranopyridine inhibitor of the AcrAB efflux pump of Escherichia coli","volume":"58","author":"Opperman","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B51","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1016\/j.bbapap.2008.12.011","article-title":"Mechanisms of drug efflux and strategies to combat them: challenging the efflux pump of Gram-negative bacteria","volume":"1794","author":"Pages","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"B52","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1016\/j.vetmic.2013.12.021","article-title":"Pharmacokinetic-pharmacodynamic (PK-PD) modeling and the rational selection of dosage regimes for the prudent use of antimicrobial drugs","volume":"171","author":"Papich","year":"2014","journal-title":"Vet. Microbiol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1128\/AAC.05509-11","article-title":"Involvement of the AcrAB-TolC efflux pump in the resistance, fitness, and virulence of Enterobacter cloacae","volume":"56","author":"P\u00e9rez","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"6256","DOI":"10.1128\/AAC.01085-12","article-title":"Effect of transcriptional activators SoxS, RobA, and RamA on expression of multidrug efflux pump AcrAB-TolC in Enterobacter cloacae","volume":"56","author":"P\u00e9rez","year":"","journal-title":"Antimicrob. Agents Chemother."},{"key":"B55","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1093\/jac\/dkw481","article-title":"Public health risk of antimicrobial resistance transfer from companion animals","volume":"72","author":"Pomba","year":"2017","journal-title":"J. Antimicrob. Chemother."},{"key":"B56","doi-asserted-by":"publisher","first-page":"614541","DOI":"10.3389\/fvets.2021.614541","article-title":"The skin microbiome and antimicrobial resistance in companion animals: a one Health perspective","volume":"8","author":"Pomba","year":"2021","journal-title":"Front. Vet. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"e0285170","DOI":"10.1371\/journal.pone.0285170","article-title":"The economic burden of antibiotic resistance: a systematic review and meta-analysis","volume":"18","author":"Poudel","year":"2023","journal-title":"PLOS ONE"},{"key":"B58","doi-asserted-by":"publisher","first-page":"1706","DOI":"10.1111\/jvim.17043","article-title":"Effect of institutional antimicrobial stewardship guidelines on prescription of critically important antimicrobials for dogs and cats","volume":"38","author":"Robbins","year":"2024","journal-title":"J. Vet. Intern. Med."},{"key":"B59","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/nm1347","article-title":"Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase","volume":"12","author":"Robicsek","year":"2006","journal-title":"Nat. Med."},{"key":"B60","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1128\/AAC.06422-11","article-title":"Expression of the resistance-nodulation-cell division pump AdeIJK in Acinetobacter baumannii is regulated by AdeN, a TetR-type regulator","volume":"56","author":"Rosenfeld","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"B61","doi-asserted-by":"publisher","first-page":"59","DOI":"10.2174\/1874285801307010059","article-title":"Multidrug efflux pumps in Staphylococcus aureus: an update","author":"Santos Costa","year":"2013","journal-title":"Open Microbiol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1292\/jvms.12-0186","article-title":"Contribution of the AcrAB-TolC efflux pump to high-level fluoroquinolone resistance in Escherichia coli isolated from dogs and humans","volume":"75","author":"Sato","year":"2013","journal-title":"J. Vet. Med. Sci."},{"key":"B63","doi-asserted-by":"publisher","first-page":"25","DOI":"10.2460\/ajvr.72.1.25","article-title":"Evaluation of the contribution of gyrA mutation and efflux pumps to fluoroquinolone and multidrug resistance in pathogenic Escherichia coli isolates from dogs and cats","volume":"72","author":"Shaheen","year":"2011","journal-title":"Am. J. Vet. Res."},{"key":"B64","doi-asserted-by":"publisher","first-page":"129","DOI":"10.4103\/ijmr.IJMR_2079_17","article-title":"Efflux pump inhibitors for bacterial pathogens: from bench to bedside","volume":"149","author":"Sharma","year":"2019","journal-title":"Indian J. Med. Res."},{"key":"B65","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.3389\/fmicb.2017.01868","article-title":"Boeravinone B, a novel dual inhibitor of NorA bacterial efflux pump of Staphylococcus aureus and human P-glycoprotein, reduces the biofilm formation and intracellular invasion of bacteria","volume":"8","author":"Singh","year":"2017","journal-title":"Front. Microbiol."},{"key":"B66","doi-asserted-by":"publisher","first-page":"2057","DOI":"10.3389\/fmicb.2020.02057","article-title":"Tolerance and persistence of Pseudomonas aeruginosa in biofilms exposed to antibiotics: molecular mechanisms, antibiotic strategies and therapeutic perspectives","volume":"11","author":"Soares","year":"2020","journal-title":"Front. Microbiol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1128\/CMR.00016-09","article-title":"Plasmid-mediated quinolone resistance: a multifaceted threat","volume":"22","author":"Strahilevitz","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"key":"B68","doi-asserted-by":"publisher","first-page":"4362","DOI":"10.1128\/AAC.49.10.4362-4364.2005","article-title":"AbeM, an H+-coupled Acinetobacter baumannii multidrug efflux pump belonging to the MATE family of transporters","volume":"49","author":"Su","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"B69","doi-asserted-by":"publisher","first-page":"7250","DOI":"10.1128\/AAC.03728-14","article-title":"Properties of AdeABC and AdeIJK efflux systems of Acinetobacter baumannii compared with those of the AcrAB-TolC system of Escherichia coli","volume":"58","author":"Sugawara","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"B70","doi-asserted-by":"publisher","first-page":"e0100123","DOI":"10.1128\/aac.01001-23","article-title":"NorA efflux pump mediates Staphylococcus aureus response to Pseudomonas aeruginosa pyocyanin toxicity","volume":"68","author":"Truong-Bolduc","year":"2024","journal-title":"Antimicrob. Agents Chemother."},{"key":"B71","doi-asserted-by":"publisher","first-page":"29","DOI":"10.2165\/00003495-199958002-00006","article-title":"Pharmacokinetics and pharmacodynamics of fluoroquinolones","volume":"58","author":"Turnidge","year":"1999","journal-title":"Drugs"},{"key":"B72","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.ijantimicag.2009.10.012","article-title":"High-level ciprofloxacin resistance among hospital-adapted Enterococcus faecium (CC17)","volume":"35","author":"Werner","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"B73","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.resmic.2017.10.005","article-title":"Regulation of the AcrAB-TolC efflux pump in Enterobacteriaceae","volume":"169","author":"Weston","year":"2018","journal-title":"Res. Microbiol."},{"key":"B74","volume-title":"Global Antimicrobial Resistance and Use Surveillance System (GLASS) Report: Antibiotic Use Data for 2022","year":""},{"key":"B75","volume-title":"Global Antibiotic Resistance Surveillance Report 2025","year":""},{"key":"B76","doi-asserted-by":"publisher","first-page":"3354","DOI":"10.1128\/AAC.00339-07","article-title":"New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate","volume":"51","author":"Yamane","year":"2007","journal-title":"Antimicrob. Agents Chemother."},{"key":"B77","doi-asserted-by":"publisher","first-page":"2989","DOI":"10.1128\/AAC.02556-12","article-title":"RND-type efflux pumps in multidrug-resistant clinical isolates of Acinetobacter baumannii: major role for AdeABC overexpression and AdeRS mutations","volume":"57","author":"Yoon","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"B78","doi-asserted-by":"publisher","first-page":"e0206919","DOI":"10.1128\/AAC.02069-19","article-title":"Development of tigecycline resistance in carbapenemase-producing Klebsiella pneumoniae sequence type 147 via AcrAB overproduction mediated by replacement of the ramA promoter","volume":"64","author":"Yoon","year":"2020","journal-title":"Antimicrob. Agents Chemother."},{"key":"B79","doi-asserted-by":"publisher","first-page":"7087","DOI":"10.1016\/j.bmc.2007.07.039","article-title":"MexAB-OprM specific efflux pump inhibitors in Pseudomonas aeruginosa. Part 7: highly soluble and in vivo active quaternary ammonium analogue D13-9001, a potential preclinical candidate","volume":"15","author":"Yoshida","year":"2007","journal-title":"Bioorg. Med. Chem."}],"container-title":["Frontiers in Pharmacology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1897593\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T13:48:55Z","timestamp":1784728135000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fphar.2026.1897593\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,22]]},"references-count":78,"alternative-id":["10.3389\/fphar.2026.1897593"],"URL":"https:\/\/doi.org\/10.3389\/fphar.2026.1897593","relation":{},"ISSN":["1663-9812"],"issn-type":[{"value":"1663-9812","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,22]]},"article-number":"1897593"}}